These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 6753547)

  • 1. Hemodynamic effects of salbutamol, an oral long-acting beta-stimulant, in patients with congestive heart failure.
    Mifune J; Kuramoto K; Ueda K; Matsushita S; Kuwajima I; Sakai M; Iwasaki T; Moroki N; Murakami M
    Am Heart J; 1982 Nov; 104(5 Pt 1):1011-5. PubMed ID: 6753547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detrimental arrhythmogenic and sustained beneficial hemodynamic effects of oral salbutamol in patients with chronic congestive heart failure.
    Mettauer B; Rouleau JL; Burgess JH
    Am Heart J; 1985 Apr; 109(4):840-7. PubMed ID: 3984838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Haemodynamic effects of oral salbutamol alone and in combination with sublingual isosorbide dinitrate in patients with severe congestive cardiac failure.
    Stephens JD; Banim SO; Spurrell RA
    Br Heart J; 1980 Feb; 43(2):220-5. PubMed ID: 7362716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemodynamic effects of oral pirbuterol in chronic severe congestive heart failure.
    Awan NA; Evenson MK; Needham KE; Evans TO; Hermanovich J; Taylor CR; Amsterdam E; Mason DT
    Circulation; 1981 Jan; 63(1):96-101. PubMed ID: 7438412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemodynamic assessment of oral peripheral vasodilator therapy in chronic congestive heart failure: prolonged effectiveness of isosorbide dinitrate.
    Williams DO; Bommer WJ; Miller RR; Amsterdam EA; Mason DT
    Am J Cardiol; 1977 Jan; 39(1):84-90. PubMed ID: 318795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative hemodynamic effects of chewable isosorbide dinitrate and nitroglycerin in patients with congestive heart failure.
    Mikulic E; Franciosa JA; Cohn JN
    Circulation; 1975 Sep; 52(3):477-82. PubMed ID: 808359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Salbutamol in treatment of heart failure.
    Bourdillon PD; Dawson JR; Foale RA; Timmis AD; Poole-Wilson PA; Sutton GC
    Br Heart J; 1980 Feb; 43(2):206-10. PubMed ID: 7362714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiocirculatory effects of afterload reduction with oral trimazosin in severe chronic congestive heart failure.
    Awan NA; Hermanovich J; Whitcomb C; Skinner P; Mason DT
    Am J Cardiol; 1979 Jul; 44(1):126-31. PubMed ID: 453037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemodynamic and metabolic effects of isosorbide dinitrate in chronic congestive heart failure.
    Gray R; Chatterjee K; Vyden JK; Ganz W; Forrester JS; Swan HJ
    Am Heart J; 1975 Sep; 90(3):346-52. PubMed ID: 1163426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute hemodynamic effect of oral nifedipine in severe chronic congestive heart failure.
    Elkayam U; Weber L; Torkan B; Berman D; Rahimtoola SH
    Am J Cardiol; 1983 Nov; 52(8):1041-5. PubMed ID: 6637820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute hemodynamic effect of oral MDL 17,043 in severe congestive heart failure.
    Uretsky BF; Generalovich T; Reddy PS; Salerni R; Valdes AM; Spangenberg RB; Lang JF; Okerholm RA
    Am J Cardiol; 1984 Aug; 54(3):357-62. PubMed ID: 6235735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The acute hemodynamic effects of a new agent, MDL 17,043, in the treatment of congestive heart failure.
    Uretsky BF; Generalovich T; Reddy PS; Spangenberg RB; Follansbee WP
    Circulation; 1983 Apr; 67(4):823-8. PubMed ID: 6218939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemodynamic action of nicorandil in chronic congestive heart failure.
    Solal AC; Jaeger P; Bouthier J; Juliard JM; Dahan M; Gourgon R
    Am J Cardiol; 1989 Jun; 63(21):44J-48J. PubMed ID: 2525325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Orally administered isosorbide dinitrate in patients with and without left ventricular failure due to acute myocardial infarction.
    Bussmann WD; Löhner J; Kaltenbach M
    Am J Cardiol; 1977 Jan; 39(1):91-6. PubMed ID: 318796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Failure of low doses of amrinone to produce sustained hemodynamic improvement in patients with severe chronic congestive heart failure.
    Packer M; Medina N; Yushak M
    Am J Cardiol; 1984 Nov; 54(8):1025-9. PubMed ID: 6496324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic effects of a combined salbutamol-nitroprusside regimen in acute myocardial infarction and severe left ventricular failure.
    Fowler MB; Timmis AD; Chamberlain DA
    Br Med J; 1980 Feb; 280(6212):435-7. PubMed ID: 7370524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beneficial hemodynamic effects of oral levodopa in heart failure. Relation to the generation of dopamine.
    Rajfer SI; Anton AH; Rossen JD; Goldberg LI
    N Engl J Med; 1984 May; 310(21):1357-62. PubMed ID: 6717507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The hemodynamic actions of the antiarrhythmic agent ipazilide fumarate in patients with congestive heart failure.
    Gottlieb SS; Cines M; Pressel MD
    Clin Pharmacol Ther; 1994 Jul; 56(1):75-81. PubMed ID: 8033497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variability of hemodynamic responses to acute digitalization in chronic cardiac failure due to cardiomyopathy and coronary artery disease.
    Cohn K; Selzer A; Kersh ES; Karpman LS; Goldschlager N
    Am J Cardiol; 1975 Apr; 35(4):461-8. PubMed ID: 1119395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined hemodynamic effects of nifedipine and nitroglycerin in congestive heart failure.
    Kubo SH; Fox SC; Prida XE; Cody RJ
    Am Heart J; 1985 Nov; 110(5):1032-4. PubMed ID: 3933315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.